ReCLAIM-2: Phase 2 Trial of Subcutaneous Elamipretide in Patients with Noncentral Geographic Atrophy
Time: 12:30 pm
day: Day Two
Details:
- Elamipretide is a first in class mitochondrial restorative compound
- Review results of phase 2 trial demonstrating positive secondary endpoints and possible path to phase 3 enrichment
- Cover ellipsoid zone endpoint and how it relates to mitochondrial health
